Trial Profile
Pemetrexed Alone as Salvage Treatment in Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy: A Phase II Single Arm Prospective Study
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 Jun 2022
Price :
$35
*
At a glance
- Drugs Pemetrexed (Primary) ; Cobalamin; Folic acid
- Indications Colorectal cancer
- Focus Therapeutic Use
- 13 Jun 2022 Planned End Date changed from 1 Dec 2020 to 1 Dec 2023.
- 13 Jun 2022 Planned primary completion date changed from 1 Dec 2020 to 1 Dec 2022.
- 13 Jun 2022 Status changed from recruiting to active, no longer recruiting.